Sunfox Technologies, the health tech startup from Shark Tank India fame, has received another ₹15 crore in the pre-series funding round. This funding round was done by a repeat investor called Venture Catalysts with the help of some other prominent investors. These funds would go a long way in propelling Sunfox to deliver on its vision of dramatically transforming cardiac care with invention.
Empowerment of Cardiac Health
The core of Sunfox’s activities is its key product, Spandan. Launched under the in-house research and development (R&D) lab, Spandan is a portable ECG (electrocardiogram) device that works on the smartphone. Currently, Spandan offers 12-lead ECG results with clinical correctness, allowing users to track their heart health in real time.
Having provided education about how to pinpoint a heart attack, Spandan has helped save more than 10,001 lives in as many as twenty countries. Its importance is especially significant as India finds itself with higher heart attack rates after COVID-19. Adopted across the geographical world, Spandan has proved its inherent life-saving potential for over 30,000 users.
Vision of Sunfox Technologies
Sunfox Technologies was initiated in 2016 by Rajat Jain & Arpit Jain of Techbound Solutions along with co-founders Saurabh Badola, Nitin Chandola, and Sabit Rawat. Their vision is to create innovative healthcare technologies that are not so far apart from conventional medicine and technology. An example of this approach is Spandan, which can help users worldwide and provide accurate data on cardiac output measurement.
Growth of Sunfox Technologies
Sunfox to expand the reach of Spandan across India and around the world. These investments will be made in research and development to improve products and innovate to come up with better solutions. The finished products manufacturing facility developed at Dehradun makes it even stronger as Sunfox has an advanced in-house production line.
Image Source: Sunfox Technologies
Sunfox working on other innovations
Sunfox Technologies is indeed a pioneer in the Health tech sphere. Other than Spandan which is their unique product that marks a new era in cardiac treatment they are incredibly involved with other tremendous projects. The article describes the role of smart health solutions envisioned by Sunfox, which seeks to bring change to the healthcare industry by leveraging interconnected technology. They particularly focus on creating diagnostic ECG devices that rely on computer-aided engineering, Artificial intelligence, and IoT systems. Sunfox categories involve seven years of research in developing portable ECG devices that assist in the early detection and treatment of heart diseases.
Future Goals of Sunfox Technologies
Sunfox Technologies, a healthcare technology startup founded in 2016 by Rajat Jain, Arpit Jain, Saurabh Badola, Nitin Chandola, and Sabit Rawat, has big plans for the future. The goal of Sunfox in the next three to five years is to expand the Spandan innovation across India and other countries. Clinically validated 12-lead ECG readings are accessible through Spandan, a smartphone-based portable ECG device, which enables users to detect heart attacks or monitor cardiac health instantly. Now, it is used by over 30,000 people in 20 countries and helps save more than 10,000 people due to timely identification of heart problems.
Relying on the fact that Sunfox has embarked on R&D, means that they are still exploring better ways of expanding their operations. This interest in the creation of new Healthcare technologies for the virtual world fuels their passion for innovation. They are intended as improvements of existing products and the creation of new ones that fill the space between pharma and technology. Sunfox has already set up a sophisticated cutting-edge manufacturing campus in Dehradun. This facility enhances their capacities and guarantees the production of their lifesaving equipment.
Conclusion
Sunfox has not been left behind in this respect and has recorded the following accomplishments. The company can attract interest from various parts of the world including Oxford and Wharton. It is also evident that their passion is geared towards enhancing performance in cardiac care, as informed by the ever-growing domain of digital health and innovation.
